Aadi Bioscience Inc AADI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:42 PM EDT
1.90quote price arrow down-0.01 (-0.52%)
Volume
8,735,896
Close
1.91quote price arrow down-0.01 (-0.26%)
Volume
92,205
52 week range
1.55 - 8.60
Loading...
  • Open1.93
  • Day High1.93
  • Day Low1.89
  • Prev Close1.92
  • 52 Week High8.60
  • 52 Week High Date05/23/23
  • 52 Week Low1.55
  • 52 Week Low Date01/18/24

Key Stats

  • Market Cap46.899M
  • Shares Out24.55M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.66
  • YTD % Change-5.45

KEY STATS

  • Open1.93
  • Day High1.93
  • Day Low1.89
  • Prev Close1.92
  • 52 Week High8.60
  • 52 Week High Date05/23/23
  • 52 Week Low1.55
  • 52 Week Low Date01/18/24
  • Market Cap46.899M
  • Shares Out24.55M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.66
  • YTD % Change-5.45

RATIOS/PROFITABILITY

  • EPS (TTM)-2.55
  • P/E (TTM)-0.75
  • Fwd P/E (NTM)-0.73
  • EBITDA (TTM)-74.439M
  • ROE (TTM)-58.22%
  • Revenue (TTM)23.84M
  • Gross Margin (TTM)87.70%
  • Net Margin (TTM)-288.72%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aadi Bioscience Inc

 

Content From Our Affiliates

Profile

MORE
Aadi Bioscience, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on developing and commercializing precision therapies for cancers with alterations in the mammalian target of rapamycin (mTOR) pathway, a regulator of cell growth and cancer progression. Its lead drug product, FYARRO, is an mTOR inhibitor indicated for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor...
Caley Castelein M.D.
Non-Executive Independent Chairman of the Board
David Lennon
President, Chief Executive Officer, Principal Executive Officer
Scott Giacobello
Chief Financial Officer
Address
17383 Sunset Avenue, Suite A250
Pacific Palisades, CA
90272
United States

Top Peers

SYMBOLLASTCHG%CHG
RPID
Rapid Micro Biosystems Inc
0.8301+0.0101+1.2317%
OCUP
Ocuphire Pharma Inc
1.69-0.05-2.88%
TBIO
Telesis Bio Inc
4.46+0.11+2.53%
CARA
Cara Therapeutics Inc
0.7501-0.0551-6.843%
MRNS
Marinus Pharmaceuticals Inc
1.33+0.03+2.31%